Overview

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This trial is being conducted as an open-label, extended-term study for patients with chronic hepatitis B who have previously completed an Idenix-sponsored trial with telbivudine.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Telbivudine